Search

everythinglearnresearchcommunity

for

Search:↓

Poor sleep, physical health, depression, and anxiety can worsen urinary problems in men.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Urinary Se to creatinine ratio, serum Se, and glutathione peroxidase are effective early biomarkers for selenium status in dogs.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

Marijuana use is linked to higher chances of needing treatment for urinary symptoms in men over 40.

Men with depression and marijuana usage are more likely to be treated for lower urinary tract symptoms/benign prostatic hyperplasia.

Finasteride improves urinary function in men for 2 years.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Obesity is linked to more severe lower urinary tract symptoms.

Saw palmetto is not proven to improve urinary flow, prostate size, or hair loss.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Taking sildenafil and finasteride together is safe and improves urinary and sexual symptoms in BPH patients.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

Finasteride is a cost-effective option for treating BPH, reducing risk of urinary issues and surgery.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Chewing betel nut may increase the risk of type 2 diabetes, and saw palmetto can improve urinary symptoms in BPH with fewer side effects but may cause bleeding and allergic reactions.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Passiflora incarnata may help with anxiety but has risks and drug interactions. There's a genetic link between Fragile X Syndrome and Autism Spectrum Disorder. 6.7% of urine cultures showed hospital-acquired urinary tract infections. Children used screens more during COVID-19, causing various health complaints. Autism Spectrum Disorder is often underdiagnosed in females. Dissociative disorders in childhood sexual abuse victims are more common in males. Most pregnant teenagers are not dissatisfied with their body image but worry about weight. Diagnosing tuberculosis after knee surgery is challenging due to non-specific symptoms. Post-COVID-19 syndrome is more common in older, severely affected patients. Psychiatrists should be part of pain management teams due to the psychological aspects of pain.

The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.